Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
September 29, 2025 19:30 ET | Source: Nxera Pharma Tokyo, Japan and…
LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China
September 28, 2025 19:30 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE,…
Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan
BEDFORD, Mass. and CHICAGO and TOKYO, Sept. 24, 2025 (GLOBE NEWSWIRE) --…
Spider Labs Rebrands as Marketing Security Platform to Strengthen Digital Risk Protection
TOKYO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Spider Labs Inc., provider of…
Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs REMONY for Advanced Health Monitoring and Heatstroke Safety
TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:…
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being…
Huawei Shares Industrial Challenges at the 2025 ICPC World Finals
BAKU, Azerbaijan, Sept. 10, 2025 /PRNewswire/ -- The St. Petersburg State University team…
Nippon Life India Asset Management (NAM India) Strengthening Indo-Japan Ties: Sundeep Sikka
MUMBAI, India, Sept. 1, 2025 /PRNewswire/ -- Nippon Life India Asset Management…
AIP Capital and BeYoke Capital Form Strategic Partnership
AIP Capital and BeYoke have formed a strategic partnership to originate aircraft…
CTW to Participate in the Lake Street 2025 BIG9 Conference
TOKYO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- CTW Cayman (Nasdaq: CTW) (“CTW”…